The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study - Scorecard - MDSpire

The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study

  • By

  • Alberto Floris

  • Leonardo Sichi

  • Agnese Favale

  • Marcella Falconi

  • Andrea Pace

  • Maria Maddalena Angioni

  • Angelo Italia

  • Raffaela Piras

  • Federica Olla

  • Francesca Onnis

  • Matteo Piga

  • Massimo Claudio Fantini

  • Sara Onali

  • Alberto Cauli

  • May 12, 2026

  • 0 min

Share

Clinical Scorecard: The Impact of a Collaborative Multidisciplinary Strategy on the Timely and Accurate Diagnosis of Spondyloarthritis Associated with Inflammatory Bowel Disease: Findings from a Cross-Sectional Analysis

At a Glance

CategoryDetail
ConditionSpondyloarthritis associated with inflammatory bowel disease (IBD-SpA)
Key MechanismsCollaboration between gastroenterologists and rheumatologists for diagnosis and management
Target PopulationPatients with inflammatory bowel disease (IBD)
Care SettingOutpatient clinic

Key Highlights

  • 81 patients had a prior diagnosis of SpA; 117 were suspected cases of IBD-SpA.
  • 15% of suspected cases were confirmed as new IBD-SpA diagnoses.
  • Diagnostic delay for patients with axial involvement averaged 12.4 years.
  • 72% of newly diagnosed IBD-SpA cases led to treatment alterations.
  • 85% of suspected cases were ruled out, with 60% categorized as other arthropathies.

Guideline-Based Recommendations

Diagnosis

  • Implement a multidisciplinary strategy for screening and diagnosing IBD-SpA.
  • Utilize the DETAIL screening questionnaire and appropriate laboratory and imaging studies.

Management

  • Collaborative treatment strategies between gastroenterologists and rheumatologists.

Monitoring & Follow-up

  • Regular assessment of musculoskeletal and gastrointestinal symptoms.

Risks

  • Misdiagnosis of musculoskeletal symptoms leading to unnecessary treatment.

Patient & Prescribing Data

Patients with inflammatory bowel disease experiencing musculoskeletal symptoms.

Collaborative treatment decisions are crucial for managing IBD-SpA.

Clinical Best Practices

  • Conduct comprehensive evaluations of both MSK and GI aspects in IBD patients.
  • Differentiate IBD-SpA from other arthropathies and non-specific arthralgias.

Related Resources & Content

Original Source(s)

Related Content